Medical News Summary: Comparison trial shows Fosamax to be a winner for osteoporosis treatment


advertisement

About: Comparison trial shows Fosamax to be a winner for osteoporosis treatment
Date: 15 October 2004
Source: Onlypunjab
Medical News Summary (summary of medical news story as reported by Onlypunjab): A comparison trial concluded that Fosamax (alendronate sodium) was more effective at maintaining or increasing bone mass density than Actonel (risedronate). Fosamax is the only FDA approved treatment for osteporosis and aims to reduce the risk of fractures in postmenopausal women. However, the drugs both had side effects at a similar rate and included: abdominal pain, diarrhea, constipation, heartburn, flatulence, nausea, vomiting, joint pain, muscle pain and headache. Fosamax is not recommended for use by people suffering gastrointestinal problems.
URL: http://www.onlypunjab.com/real/fullstory-newsID-6280.html
Related Disease Topics: Osteoporosis
Related Symptom Topics: Decreased bone mass density, abdominal pain, diarrhea, constipation, heartburn, flatulence, nausea, vomiting, joint pain, muscle pain, headache

Related Medical News Channels: This medical news summary article refers to the following medical channel categories:

Medical Tools & Articles:


Next articles:

Medical Articles:
 
 
CureResearch.comTM Copyright © 2010 Health Grades, Inc. All rights reserved.
Home | Contents | Search | Site Map | Feedback | Contact Us | Terms of Use | Privacy Policy | About Us | Advertise